EU taxpayers' money and Member States' sovereignty over tobacco control are at the heart of Commissioner Olivér Várhelyi's latest clarification. His detailed financial disclosure on EU-funded studies related to tobacco regulations aims to temper concerns from some quarters about EU overreach into national competence. This topic will certainly draw attention from national governments wary of EU encroachment, tobacco industry stakeholders facing regulation, public health advocates, and the taxpayers footing the bill.
this answer comes as a response to a parliamentary question by MEPs Isabella Tovaglieri and Paolo Borchia from the PfE political group, who expressed concern about EU funds supporting studies and policy drafts that may infringe on Member States' prerogatives, especially regarding smoking bans and tobacco excise duties.
Regarding concrete details, Várhelyi's response reveals precise contract values and underscores the regulatory framework. The Commission spent approximately EUR 179,995 on a specific study about smoke-free environments and tobacco advertising. However, exact costs and time for drafting a related staff working document are unavailable. Várhelyi also emphasizes compliance with Treaty provisions that empower harmonization of excise duties, noting that policy development followed "Better Regulation" principles with comprehensive impact assessments and external studies.
Policy-wise, the Commission asserts its authority primarily through Article 113 of the Treaty on the Functioning of the EU, striking a balance between harmonizing excise duties for market functioning and ensuring public health. The Commissioner underlines the non-binding nature of some recommendations, reaffirming national sovereignty in imposing smoking bans but justifying EU-level studies to inform policy and legislative revisions.
National authorities maintain smoking regulation powers but face EU-driven harmonization pressures on excise duties, impacting domestic fiscal policy autonomy. Tobacco producers and distributors will navigate evolving tax rules informed by EU studies, potentially altering competitive landscapes and compliance costs. Public health entities may welcome evidence-based policy-making, though some may question EU involvement breadth. Taxpayers get transparency on expenditure but may weigh costs against perceived EU competence overreach.
Institutionally, this clarifies expected EU actions ahead of revising Directive 2011/64/EU. The Commission’s open communication signals continuing regulatory engagement with input reflecting stakeholder concerns. The detailed financial accountability and adherence to impact assessments aim to defuse criticism and delineate EU and national roles in tobacco control policymaking.
← Atlas › News › EU affairs & Institutions